MacroGenics | Driftsresultat



Operating Profit Lave om Dato
AbbVie USD -1490000000 5.32B 2024-12
Amgen USD 2.31B 182M 2024-12
AstraZeneca USD 2.04B 731M 2024-12
Biogen USD 441.4M 24.4M 2024-12
Bristol-Myers Squibb USD 793M 1.39B 2024-12
Daiichi Sankyo JPY 61.41B 32.51B 2024-12
Eli Lilly USD 5.15B 3.62B 2024-12
Genmab DKK 2.19B 89M 2024-12
Geron USD -21757000 6.46M 2024-12
Gilead Sciences USD 2.45B 1.56B 2024-12
J&J USD 3.89B 549M 2024-12
MacroGenics USD 54.19M 112.37M 2024-09
Merck USD 4.3B 369M 2024-12
Pfizer USD -409000000 5.57B 2024-12
Regeneron Pharmaceuticals USD 990.2M 189.3M 2024-12
Roche Holding CHF 4.39B 1.04B 2024-12
Xencor USD 4.05M 66.33M 2024-12



MacroGenics Driftsresultat - Aktuelle værdier, historiske data, prognoser, statistik, diagrammer og økonomisk kalender - Mar 2025.